Literature DB >> 3743625

Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking.

R Fleischmann, H Remmer, U Stärz.   

Abstract

Human liver 10-20 mg from biopsy samples removed for diagnostic purposes from selected patients has been used for the preparation of microsomes. The activity of certain mono-oxygenases and UDP-glucuronyltransferases, as well as certain other enzymes involved in drug metabolism, has been determined using different substrates as indicators. Smokers oxidized benzo(a)pyrene and 7-ethoxyresorufin and also conjugated alpha-naphthol at a significantly increased rate compared to non-smokers. This indicates induction of certain mono-oxygenases and glucuronyltransferases which differs from the induction produced by phenobarbital. The findings can account for the reduced activity and increased elimination rate of certain drugs prescribed to smokers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743625     DOI: 10.1007/bf00607963

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  31 in total

1.  Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver.

Authors:  C H WILLIAMS; H KAMIN
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

2.  Microsomal TPNH-cytochrome c reductase.

Authors:  H Kamin; B S Masters; Q H Gibson; C H Williams
Journal:  Fed Proc       Date:  1965 Sep-Oct

3.  Characterisation of cytochrome P-450 species in rat liver microsomes, I. Differences in the O-dealkylation of 7-ethoxycoumarin after pretreatment with phenobarbital and 3-methylcholanthrene.

Authors:  V Ullrich; U Frommer; P Weber
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973-05

4.  Drowsiness due to chlorpromazine in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  C Swett
Journal:  Arch Gen Psychiatry       Date:  1974-08

5.  Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age.

Authors: 
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

6.  Clinical toxocity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt
Journal:  Chest       Date:  1978-04       Impact factor: 9.410

7.  Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene.

Authors:  M D Burke; R T Mayer
Journal:  Drug Metab Dispos       Date:  1974 Nov-Dec       Impact factor: 3.922

8.  Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-de-ethylation.

Authors:  M D Burke; R A Prough; R T Mayer
Journal:  Drug Metab Dispos       Date:  1977 Jan-Feb       Impact factor: 3.922

9.  Purification of rat-liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital.

Authors:  K W Bock; D Josting; W Lilienblum; H Pfeil
Journal:  Eur J Biochem       Date:  1979-07

10.  Cigarette smoking and theophylline clearance and metabolism.

Authors:  J J Grygiel; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

View more
  11 in total

1.  Lack of effect of short-term passive smoking on the metabolic disposition of theophylline.

Authors:  D T Casto; B M Schnapf; M A Clotz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The comparison of some pharmacokinetic parameters of sulphadimethoxine estimated by high performance liquid chromatography and three spectrophotometric methods.

Authors:  A Klimowicz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

Review 3.  Drug interactions with tobacco smoking. An update.

Authors:  S Zevin; N L Benowitz
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 4.  Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine.

Authors:  H Remmer
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

5.  Nicotine and estrogen metabolism--possible implications of smoking for growth and outcome of treatment of hormone-dependent cancer? Discussion of experimental results.

Authors:  W J Zeller; M R Berger
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.

Authors:  Anna-Britta Lind; Margareta Reis; Finn Bengtsson; Michele Jonzier-Perey; Kerry Powell Golay; Johan Ahlner; Pierre Baumann; Marja-Liisa Dahl
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 7.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

8.  Genotoxic risk for humans due to work place exposure to ethylene oxide: remarkable individual differences in susceptibility.

Authors:  J Fuchs; U Wullenweber; J G Hengstler; H G Bienfait; G Hiltl; F Oesch
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 9.  Metabolism of tricyclic antidepressants.

Authors:  M V Rudorfer; W Z Potter
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

10.  Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.

Authors:  Michael H Court
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.